4.8 Article

Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus

Vincenzo Restivo et al.

Summary: This study assessed the cardiovascular risk among patients with rheumatic diseases, finding that patients with systemic lupus erythematosus (SLE) have a higher risk of symptomatic cardiovascular events. Additionally, younger age, studies conducted in non-America locations, studies conducted after 2000, and higher quality scores were associated with an increased risk of cardiovascular events.

AUTOIMMUNITY REVIEWS (2022)

Article Dermatology

DNA chip-based diagnosis of onychomycosis and tinea pedis

Katja Bieber et al.

Summary: This study compared the diagnostic value of DNA-chip technology with microscopy and culture in diagnosing OM and TP, and found that DNA-chip technology has high sensitivity, especially when combined with microscopy.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2022)

Review Rheumatology

Update on the diagnosis and management of systemic lupus erythematosus

Antonis Fanouriakis et al.

Summary: Systemic lupus erythematosus (SLE) is characterized by clinical heterogeneity, unpredictable course and flares. Diagnosis remains clinical with limited serologic test confirmation, and newer classification criteria offer more accurate classification. Treatment goals focus on patient survival, flare prevention, organ damage prevention, and quality of life optimization. High-intensity immunosuppressive therapy followed by less intensive therapy is typically used to control disease activity in severe cases of SLE.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Review Immunology

Rheumatoid arthritis: Extra-articular manifestations and comorbidities

Fabiana Assunta Figus et al.

Summary: Synovitis is the primary manifestation of rheumatoid arthritis (RA), but many extra-articular manifestations and comorbidities are likely due to the chronic, complex nature of the disease. Cardiovascular disease is the leading cause of death in RA patients, with increased risks of myocardial infarction and CV mortality. Other common causes of death in RA patients include respiratory disease and neurological issues, with evidence linking systemic inflammation to Alzheimer's disease and vascular dementia. In order to reduce morbidity and mortality, physicians must actively manage RA disease activity and monitor for potential risk factors and associated conditions.

AUTOIMMUNITY REVIEWS (2021)

Review Dermatology

Management of psoriasis as a systemic disease: what is the evidence?

N. J. Korman

BRITISH JOURNAL OF DERMATOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Cardiovascular Risk in Patients With Psoriasis

Michael S. Garshick et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Dermatology

Psoriasis and Co-morbidity

Mina Amin et al.

ACTA DERMATO-VENEREOLOGICA (2020)

Article Dermatology

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

Craig A. Elmets et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Review Medicine, General & Internal

Epidermolysis Bullosa Acquisita: The 2019 Update

Hiroshi Koga et al.

FRONTIERS IN MEDICINE (2019)

Review Medicine, General & Internal

Diagnosis of Autoimmune Blistering Diseases

Mareike Witte et al.

FRONTIERS IN MEDICINE (2018)

Letter Dermatology

Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany

Franziska Huebner et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Review Medicine, General & Internal

Interpretation of the evidence for the efficacy and safety of statin therapy

Rory Collins et al.

LANCET (2016)

Review Dermatology

Bullous Systemic Lupus Erythematosus: A Review and Update to Diagnosis and Treatment

James J. Contestable et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2014)

Review Dermatology

Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature

H. Reddy et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)

Article Dermatology

Epidermolysis Bullosa Acquisita: A Retrospective Clinical Analysis of 30 Cases

Jong Hoon Kim et al.

ACTA DERMATO-VENEREOLOGICA (2011)

Review Pharmacology & Pharmacy

Current concepts in the treatment of epidermolysis bullosa acquisita

Hakan M. Guercan et al.

EXPERT OPINION ON PHARMACOTHERAPY (2011)

Article Dermatology

Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany

Franziska Bertram et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2009)